These studies suggest that even though diabetic nephropathy is a multicomponent disease (i.e., has features of many primary glomerular diseases, and more), the contribution of hyposialylated Angptl4 to this disorder is prominent, and warrants therapy. The gene discussed is ANGPTL4; the disease is diabetic kidney disease.